LZ-001

N/A

Report date: 2026/02/01 20:00:10
NME

Base Information

Drug NameLZ-001
Drug Alias NameLZ-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProto-oncogene tyrosine-protein kinase ROS inhibitorsTropomyosin-related kinase inhibitorsAnaplastic lymphoma kinase inhibitors
TargetsProto-oncogene tyrosine-protein kinase ROSTropomyosin-related kinaseAnaplastic lymphoma kinase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesLivzon Pharmaceutical Group Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesLivzon Pharmaceutical Group Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A